MedPath

STUDY HELD TO SEE THE EFFECT OF KANAKSUNDAR RAS (TABLETS) WITH HINGU LAYER (LEPA) IN THE MANAGEMENT OF PAINFUL MENSTURATION.

Phase 2
Conditions
Health Condition 1: N944- Primary dysmenorrhea
Registration Number
CTRI/2021/12/038821
Lead Sponsor
Dr Himakshi Tanwar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) AGE GROUP FROM 15 TO 25

2) FEMALE PATIENTS WHO ARE HAVING KASHTARTAV(DYSMENORRHOEA) HAVING PAIN ONLY.

Exclusion Criteria

1)UTERINE FIBROID.

2)STD

3)ATYARTAVA(MENORREHGIA)

4)RAKTAPRADRA(ABNORMAL UTERINE BLEEDING)

5)PATINT WITH OTHER SYSTEMIC DISORDERS LIKE DIABETES HTN ETC.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO STUDY THE COMBINED EFFECT OF KANAKSUNDAR RAS WITH HINGU LEPA IN REDUCTION OF PAIN IN KASHTARTAV.Timepoint: FOR 2 CONSECUTIVE MENSTRUAL CYCLE.
Secondary Outcome Measures
NameTimeMethod
TO OBSERVE ANY OTHER OUTCOMES OF KANAKSUNDAR RAS WITH HINGU LEPA IN KASHTARTAV.Timepoint: FOR 2 CONSECUTIVE MENSTRUAL CYCLE.
© Copyright 2025. All Rights Reserved by MedPath